Title
Category
Credits
Event date
Cost
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Updates in Prognosis and Treatment
  • Chronic Lymphocytic Leukemia
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
$0.00
The prognostic significance of molecular and cytogenetic variables vary depending on the treatment regimens and clinical outcomes being evaluated. A precise understanding of the prognostic significance of these variables is essential for the appropriate selection of patients who might benefit from specific targeted therapies with small molecule inhibitors.